High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia, a Phase 2 Trial.

被引：0
|
作者：
Powell, Bayard [1 ]
D'Agostino, Ralph, Jr. [1 ]
Levitan, Denise [1 ]
Ellis, Leslie Renee [1 ]
Lyerly, Susan [1 ]
Skiles, Megan [1 ]
Manuel, Megan [1 ]
Harrelson, Robin [1 ]
Kimbrough, Claire [1 ]
Hurd, David Duane [1 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [41] SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia
    Advani, Anjali S.
    McDonough, Shannon
    Coutre, Steven
    Wood, Brent
    Radich, Jerald
    Mims, Martha
    O'Donnell, Margaret
    Elkins, Stephanie
    Becker, Michael
    Othus, Megan
    Appelbaum, Frederick R.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (04) : 504 - 509
  • [42] PHARMACOKINETICS OF SELINEXOR IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA: A PHASE I TRIAL.
    Badawi, M.
    Walker, A.
    Mims, A.
    Vasu, S.
    Blum, W.
    Klisovic, R.
    Bhatnagar, B.
    Phelps, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S51 - S51
  • [43] Randomized phase II trial of the nucleolin targeting aptamer AS1411 combined with high-dose cytarabine in relapsed/refractory acute myeloid leukemia (AML)
    Stuart, R. K.
    Stockerl-Goldstein, K.
    Cooper, M.
    Devetten, M.
    Herzig, R.
    Medeiros, B.
    Schiller, G.
    Wei, A.
    Acton, G.
    Rizzieri, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [44] A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
    Pardee, Timothy S.
    Anderson, Rebecca G.
    Pladna, Kristin M.
    Isom, Scott
    Ghiraldeli, Lais P.
    Miller, Lance D.
    Chou, Jeff W.
    Jin, Guangxu
    Zhang, Wei
    Ellis, Leslie R.
    Berenzon, Dmitriy
    Howard, Dianna S.
    Hurd, David D.
    Manuel, Megan
    Dralle, Sarah
    Lyerly, Susan
    Powell, Bayard L.
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (09) : 2060 - 2073
  • [45] Is Intermediate-Dose Cytarabine a Good Control for Patients with Relapsed or Refractory Acute Myeloid Leukemia?
    Bertoli, Sarah
    Gadaud, Noemie
    Tavitian, Suzanne
    Sarry, Audrey
    Berard, Emilie
    Huguet, Francoise
    Recher, Christian
    [J]. BLOOD, 2016, 128 (22)
  • [46] Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
    Graveno, Molly E.
    Carulli, Alison
    Freyer, Craig W.
    Mangan, Brendan L.
    Nietupski, Robert
    Loren, Alison W.
    Frey, Noelle, V
    Porter, David L.
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Babushok, Daria, V
    Pratz, Keith W.
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1645 - 1650
  • [47] Devimistat in combination with high dose cytarabine and mitoxantrone compared with high dose cytarabine and mitoxantrone in older patients with relapsed/refractory acute myeloid leukemia: ARMADA 2000 Phase III study
    Pardee, Timothy S.
    Luther, Sanjeev
    Buyse, Marc
    Powell, Bayard L.
    Cortes, Jorge
    [J]. FUTURE ONCOLOGY, 2019, 15 (28) : 3197 - 3208
  • [48] Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
    Tse, Eric
    Leung, Anskar Y. H.
    Sim, Joycelyn
    Lee, Harold K. K.
    Liu, Herman S. Y.
    Yip, Sze-Fai
    Kwong, Yok-Lam
    [J]. ANNALS OF HEMATOLOGY, 2011, 90 (11) : 1277 - 1281
  • [49] Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
    Eric Tse
    Anskar Y. H. Leung
    Joycelyn Sim
    Harold K. K. Lee
    Herman S. Y. Liu
    Sze-Fai Yip
    Yok-Lam Kwong
    [J]. Annals of Hematology, 2011, 90 : 1277 - 1281
  • [50] Phase I Dose-Finding Study of Eltrombopag Following High Dose Cytarabine and Mitoxantrone Chemotherapy in Patients with Relapsed/Refractory Acute Myeloid Leukemia
    Swaminathan, Mahesh
    Przespolewski, Amanda
    Griffiths, Elizabeth A.
    Thompson, James E.
    Elshoury, Amro
    Walinski, Wendy
    Wang, Eunice S.
    [J]. BLOOD, 2021, 138
12345